StonvexLoading…
StonvexStonvexStonvexCore line items from CAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $67.59B | $64.81B | $67.06B | $59.43B |
Operating Income | $11.15B | $13.07B | $12.97B | $7.90B |
Net Income | $8.88B | $10.79B | $10.33B | $6.70B |
EPS (Diluted) | $18.81 | $22.05 | $20.12 | $12.64 |
Total Assets | $98.58B | $87.76B | $87.48B | $81.94B |
Total Liabilities | $77.27B | $68.27B | $67.97B | $66.05B |
Cash & Equivalents | $9.98B | $6.89B | $6.98B | $7.00B |
Free Cash Flow OCF − CapEx | $8.92B | $10.05B | $11.29B | $6.47B |
Shares Outstanding | 465.30M | 477.90M | 499.40M | 516.30M |